Support our sponsors:

NZX 50 Index	3315.14	2.90
S&P/ASX 200	4274.20	21.80
Dow Jones Industrials	12845.10	17.10

Twitter

Facebook

RSS

Daily ShareChat: Fisher & Paykel Healthcare

By Jenny Ruth

Monday 8th June 2009

Text too small?

Although Fisher & Paykel Healthcare's annual results were in line with expectations, management's "very downbeat" guidance for the year ending March 2010 has led Morningstar to downgrade its forecasts.

With the New Zealand dollar at 60 US cents, the company expects to achieve net profit between $75 million and $80 million. "This is well below our net profit forecast of $104 million," Morningstar says.

In late May, the respiratory humidification and obstructive sleep apnea (OSA) products company reported a 76% rise in annual net profit to $62.2 million.

"We are not too concerned about this year's earnings but are more focused on the health of the business in general which remains in good shape," Morningstar says.

"We are comfortable with the firm's strategy to invest for the future, even if it means sacrificing short-term earnings," it says.

New products launched during the year just gone should help the company regain market share in the OSA market while its respiratory humidification business will continue to deliver strong underlying growth, it says.

"We also look forward to margin uplift from savings in Mexico and expansion into other geographies."

Fisher & Paykel Healthcare is setting up a manufacturing facility in Mexico to raise capacity and free up resources at its Auckland head office.

BROKER CALL: Morningstar rate Fisher & Paykel Healthcare (NZX: FPH ) as HOLD.

Daily ShareChat articles report how the main experts in the market might view a certain share and we provide this commentary as a useful resource for investors. Content on this site does not in any way constitute a recommendation to buy, hold or sell any particular share. Investors should always seek professional advice before making any investment decisions.

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.